Joshua DeTillio is a healthcare executive with over 20 years of leadership experience in Healthcare Administration in investor-owned, public, faith based, and non-profit healthcare companies in the United States.
Beginning in 2023 Mr. DeTillio started as the Chief Operating Officer for Nutex Health.
Mr. DeTillio has worked for several large public hospital companies including HCA, Tenet, and CHS. For the last 13 years he has served as the CEO of three different hospitals in Florida including several successful turnaround efforts.
Josh has demonstrated success in collaborating with and leading boards and physicians to drive growth, improve culture, and deliver results on stated metrics in highly competitive markets. He is an accomplished leader in company strategic planning, health system operations, patient safety, and business development tactics. Mr. DeTillio is an engaging relationship builder with proven success in building highly effective leadership teams and developing a culture of teamwork and accountability.
Mr. DeTillio received his Bachelor of Science degree from the United States Military Academy at West Point. He earned a Master of Business Administration from Vanderbilt University, as well as a Master of Public Health from Harvard University. He also is a Fellow (FACHE) with the American College of Healthcare Executives.
Prior to his work in Healthcare, Mr. DeTillio served for five years in the US Army. As an Artillery officer, he served in various units including time in Oklahoma, Georgia, California, and Tennessee.
What is Joshua DeTillio's net worth?
The estimated net worth of Joshua DeTillio is at least $643.77 thousand as of August 19th, 2024. Mr. DeTillio owns 4,233 shares of Nutex Health stock worth more than $643,767 as of December 4th. This net worth estimate does not reflect any other assets that Mr. DeTillio may own. Learn More about Joshua DeTillio's net worth.
How do I contact Joshua DeTillio?
Has Joshua DeTillio been buying or selling shares of Nutex Health?
Joshua DeTillio has not been actively trading shares of Nutex Health over the course of the past ninety days. Most recently, on Monday, August 19th, Joshua Detillio bought 1,300 shares of Nutex Health stock. The stock was acquired at an average cost of $17.85 per share, with a total value of $23,205.00. Following the completion of the transaction, the chief operating officer now directly owns 4,233 shares of the company's stock, valued at $75,559.05. Learn More on Joshua DeTillio's trading history.
Who are Nutex Health's active insiders?
Are insiders buying or selling shares of Nutex Health?
In the last twelve months, Nutex Health insiders bought shares 2 times. They purchased a total of 1,750 shares worth more than $184,342.50. The most recent insider tranaction occured on November, 25th when CFO Jon Christian Bates bought 750 shares worth more than $102,532.50. Insiders at Nutex Health own 36.9% of the company.
Learn More about insider trades at Nutex Health. Information on this page was last updated on 11/25/2025.
